Seeking Alpha

Shares of Stemline Therapeutics (STML +4.5%) move up again today, hitting another 52-week high....

Shares of Stemline Therapeutics (STML +4.5%) move up again today, hitting another 52-week high. The stock has soared over 34% since Monday, when its treatment for blastic plasmacytoid dendritic cell neoplasm, SL-401, received an Orphan Drug designation from the FDA.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs